PURPRECISION Trademark

Trademark Overview

On Monday, November 29, 2021, a trademark application was filed for PURPRECISION with the United States Patent and Trademark Office. The USPTO has given the PURPRECISION trademark a serial number of 97146524. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by PurMinds Neuropharma Inc.. The PURPRECISION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of a platform as a service featuring computer programs using artificial intelligence, neuronal screening techniques, pre-clinical and clinical models or techniques both in vivo and in vitro, multi-omics studies, and machine learning for drug discovery, development, and design
purprecision

General Information

Serial Number97146524
Word MarkPURPRECISION
Filing DateMonday, November 29, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements

Pseudo MarkPUR PRECISION; PURE PRECISION
Goods and ServicesProvision of a platform as a service featuring computer programs using artificial intelligence, neuronal screening techniques, pre-clinical and clinical models or techniques both in vivo and in vitro, multi-omics studies, and machine learning for drug discovery, development, and design

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePurMinds Neuropharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M3C4H9
CA
Party NamePurMinds Neuropharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M3C4H9
CA

Trademark Events

Event DateEvent Description
Thursday, September 8, 2022ASSIGNED TO EXAMINER
Thursday, December 2, 2021NEW APPLICATION ENTERED
Thursday, December 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 23, 2022EXAMINERS AMENDMENT E-MAILED
Friday, September 23, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, September 23, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 23, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, November 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 31, 2023SOU EXTENSION 1 FILED
Monday, July 31, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 31, 2024SOU EXTENSION 3 FILED
Wednesday, January 24, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

purprecision techniques clinical omics studies multi vitro vivo machine learning design